[Tropacin in the treatment of patients with the hyperactive urinary bladder].

AIM: To examine effectiveness and tolerance of tropacin in patients with hyperactive urinary bladder (HAUB).

MATERIAL AND METHODS: 62 patients aged between 19 and 82 with hyperactive bladder have received tropacin in a dose 3-10 mg twice a day for 12 weeks. Of them 31 had idiopathic detrusor unstability (IDUS), 10 had sensory urgent disorders (SUD), 21 suffered from detrusor hyperreflexia (DHR).

RESULTS: In IDUS patients 12-week tropacin administration reduced mean daily number of urination from 14.3 to 10.9, mean daily number of episodes of inperative enuresis diminished from 3.9 to 2.2. DHR patients showed the above decrease from 15.2 to 12.7 and 4.1 to 2.2, respectively. In sensory urgency tropacin was less effective.

CONCLUSION: Tropacin is effective and safe medicine for treatment of IDUS and DHR.